Real-life evidence in evaluating effectiveness of treatment in Haemophilia A with a recombinant FVIII concentrate: A non-interventional study in emerging countries-Reference-Cited by-同舟云学术

Real-life evidence in evaluating effectiveness of treatment in Haemophilia A with a recombinant FVIII concentrate: A non-interventional study in emerging countries

Published:2015-02-04 Issue:3 Volume:21 Page:e167-e175
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Gouider E.¹,Rauchensteiner S.²,Andreeva T.³,Al Zoebie A.⁴,Mehadzic S.⁵,Nefyodova L.⁶,Brunn M.²,Tueckmantel C.⁷,Meddeb B.¹

Affiliation:

1. Service d'Hématologie Clinique Hôpital Aziza Othmana; Tunis Tunisia

2. Bayer HealthCare Pharmaceuticals; Berlin Germany

3. Comprehensive Hemophilia Care Centre; St. Petersburg Russia

4. Sheikh Khalifa Medical City; Abu Dhabi United Arab Emirates

5. Klinika za Pedijatriju; Sarajevo Bosnia-Herzegovina

6. Akmolinskaya Regional Hospital; Kokshetau Kazakhstan

7. Bayer HealthCare Pharmaceuticals; Wuppertal Germany

Funder

Bayer Healthcare

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12631/fullpdf

Reference46 articles.

1. Guidelines for the management of hemophilia;Srivastava;Haemophilia,2013

2. Treatment of hemophilia: a review of current advances and ongoing issues;Coppola;J Blood Med,2010

3. Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens;Collins;J Thromb Haemost,2010a

4. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized;Astermark;Br J Haematol,1999

5. Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study;Feldman;J Thromb Haemost,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BAY 81‐8973 prophylaxis and pharmacokinetics in haemophilia A: Interim results from the TAURUS study;European Journal of Haematology;2020-04-23

2. Show me the evidence: Effectiveness of low‐dose prophylaxis;Haemophilia;2020-04

3. Factor VIIIproducts and inhibitor development in previously treated patients with severe or moderately severe hemophilia A: a systematic review;Journal of Thrombosis and Haemostasis;2018-05-24

4. Low dose prophylaxis in Tunisian children with haemophilia;Haemophilia;2016-12-11

5. Partnering to change the world for people with haemophilia: 6thHaemophilia Global Summit, Prague, Czech Republic, 24-26thSeptember 2015;European Journal of Haematology;2016-06-13